DMTX Insider Trading Activity and SEC Form 4 Filings
DMTX insider trading summary
No open-market insider purchases or sales of Dimension Therapeutics, Inc. (DMTX) have been reported on SEC Form 4 in the past 12 months.
Latest DMTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 7, 2016 | K. Reed Clark | SVP of Pharmaceutical Develop | Sell | $50K (5,000 @ $10.00) |
| Oct 27, 2015 | Orbimed Advisors LLC | Director | Buy | $2.6M (200,000 @ $13.00) |
| Oct 27, 2015 | OrbiMed Capital GP V LLC | Director | Buy | $2.6M (200,000 @ $13.00) |
| Oct 27, 2015 | Samuel D Isaly | Director | Buy | $2.6M (200,000 @ $13.00) |
| Oct 27, 2015 | Michael Dybbs | Director | Buy | $12.5M (961,538 @ $13.00) |
| Oct 27, 2015 | Rishi Gupta | Director | Buy | $2.6M (200,000 @ $13.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.